Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 533

The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.

Glucocorticosteroids: current and future directions

Open access
Barnes, Peter J·2011·British Journal of Pharmacology

Abstract

Glucocorticoids are the most effective anti‐inflammatory therapy for asthma yet are relatively ineffective in chronic obstructive pulmonary disease. Glucocorticoids suppress inflammation via several molecular mechanisms. Glucocorticoids suppress the multiple inflammatory genes that are activated in chronic inflammatory diseases, such as asthma, by reversing histone acetylation of activated inflammatory genes through binding of ligand‐bound glucocorticoid receptors (GR) to co‐activator molecules and recruitment of histone deacetylase‐2 to the activated inflammatory gene transcription complex (trans‐repression). At higher concentrations of glucocorticoids GR homodimers interact with DNA recognition sites to activate transcription through increased histone acetylation of anti‐inflammatory genes and transcription of several genes linked to glucocorticoid side effects (trans‐activation). Glucocorticoids also have post‐transcriptional effects and decrease stability of some pro‐inflammatory mRNA species. Decreased glucocorticoid responsiveness is found in patients with severe asthma and asthmatics who smoke, as well as in all patients with chronic obstructive pulmonary disease. Several molecular mechanisms of glucocorticoid resistance have now been identified which involve post‐translational modifications of GR. Histone deacetylase‐2 is markedly reduced in activity and expression as a result of oxidative/nitrative stress so that inflammation becomes resistant to the anti‐inflammatory actions of glucocorticoids. Dissociated glucocorticoids and selective GR modulators which show improved trans‐repression over trans‐activation effects have been developed to reduce side effects, but so far it has been difficult to dissociate anti‐inflammatory effects from adverse effects. In patients with glucocorticoid resistance alternative anti‐inflammatory treatments are being investigated as well as drugs that may reverse the molecular mechanisms of glucocorticoid resistance. LINKED ARTICLES This article is part of a themed issue on Respiratory Pharmacology. To view the other articles in this issue visit http://dx.doi.org/10.1111/bph.2011.163.issue‐1

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2010.01199.x

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 133 references

Cited by

See all 533

Metadata

Authors
Barnes, P. J.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-04-06
Volume
163
Issue
1
Pages
29-43
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1605768991
Cited by
533
References
133
FWCI
18.11
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticosteroids: current and future directions. https://app.cochat.ai/papers/10.1111/j.1476-5381.2010.01199.x
The paper
Barnes, P. J. (2011). Glucocorticosteroids: current and future directions. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2010.01199.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.